ALAMAR BIOSCIENCES INC (ALMR) competitors & alternatives
Health Care · NASDAQ
ALAMAR BIOSCIENCES INC (ALMR)'s top competitors and alternatives — its most similar public companies — include Thermo Fisher Scientific (TMO), Bio-Rad Laboratories (BIO), QUANTERIX CORP (QTRX), Quantum-Si Inc (QSI), NAUTILUS BIOTECHNOLGY INC (NAUT), Bio-Techne (TECH), Bruker (BRKR), Agilent Technologies (A), ALTO NEUROSCIENCE INC (ANRO), Waters Corporation (WAT), Revvity (RVTY) and Insight Molecular Diagnostics Inc. (IMDX). These are ALAMAR BIOSCIENCES INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top ALMR competitors & alternatives
-
Thermo Fisher ScientificTMOHealth Care
Thermo Fisher Scientific is a leading global provider of mission-critical laboratory equipment, analytical instrumentation, and scientific services for…
$526.46 (as of 2026-07-22) · market cap $194.1B
-
Bio-Rad LaboratoriesBIOHealth Care
A multinational life science and clinical diagnostics company providing research tools, diagnostic test systems, and consumables to laboratories and…
$305.96 (as of 2026-07-22) · market cap $8.2B
-
QUANTERIX CORPQTRXHealth Care
Quanterix develops ultra-sensitive protein detection and spatial tissue analysis platforms for biomarker discovery and early disease diagnostics, with recent…
$3.84 (as of 2026-07-22) · market cap $181M
-
Quantum-Si IncQSIHealth Care
A proteomics instrumentation and consumables company bringing massively parallel single-molecule protein sequencing to researchers and clinicians through its…
$0.80 (as of 2026-07-22) · market cap $174M
-
NAUTILUS BIOTECHNOLGY INCNAUTHealth Care
A pre-commercial proteomics platform company developing Iterative Mapping technology to enable single-molecule protein counting for comprehensive, reproducible…
$1.70 (as of 2026-07-22) · market cap $216M
-
Bio-TechneTECHHealth Care
A leading life sciences company providing essential reagents, analytical tools, and bio-manufacturing solutions for research and clinical diagnostics.
$71.78 (as of 2026-07-22) · market cap $11.2B
-
BrukerBRKRHealth Care
Bruker is a global leader in high-performance analytical instrumentation and diagnostic solutions for life sciences and materials research, enabling structural…
$59.74 (as of 2026-07-22) · market cap $9.1B
-
Agilent TechnologiesAHealth Care
A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical…
$133.46 (as of 2026-07-22) · market cap $37.6B
-
ALTO NEUROSCIENCE INCANROHealth Care
Alto Neuroscience is a clinical-stage biotech developing precision medicines for neuropsychiatric conditions by using biomarkers to match patients to targeted…
$27.23 (as of 2026-07-22) · market cap $1.0B
-
Waters CorporationWATHealth Care
A leading global analytical instruments and life sciences company combining chromatography, mass spectrometry, and diagnostic solutions following a…
$370.82 (as of 2026-07-22) · market cap $35.9B
-
RevvityRVTYHealth Care
Revvity is a leading health science technology company providing integrated workflows and reagents spanning drug discovery, development, and diagnostic…
$110.54 (as of 2026-07-22) · market cap $12.3B
-
Insight Molecular Diagnostics Inc.IMDXHealth Care
iMDx develops decentralized molecular diagnostic kits for transplant organ rejection monitoring using donor-derived cell-free DNA biomarkers, enabling in-house…
$4.99 (as of 2026-07-22) · market cap $165M
Not quite? Describe exactly what you want →
Peers are ALAMAR BIOSCIENCES INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: ALAMAR BIOSCIENCES INC (ALMR).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.